Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Type 2 diabetes is a poor example of the overuse of surrogate markers.
Dickson I.
BMJ. 2012 Jan 31;344:e735. doi: 10.1136/bmj.e735. No abstract available.
Related citations
Hard end points are needed for intensive glycaemic control in patients with type 2 diabetes.
Yudkin JS, Lipska KJ.
BMJ. 2012 Jan 31;344:e708; author reply e710. doi: 10.1136/bmj.e708. No abstract available.
Islet transplantation in type 1 diabetes.
de Kort H, de Koning EJ, Rabelink TJ, Bruijn JA, Bajema IM.
BMJ. 2011 Jan 21;342:d217. doi: 10.1136/bmj.d217. Review. No abstract available.
Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies.
Yeung WC, Rawlinson WD, Craig ME.
BMJ. 2011 Feb 3;342:d35. doi: 10.1136/bmj.d35. Review.
Enteroviruses and type 1 diabetes.
Hober D, Sane F.
BMJ. 2011 Feb 3;342:c7072. doi: 10.1136/bmj.c7072. No abstract available.
Americans are living longer, but obesity and diabetes are rising.
Tanne JH.
BMJ. 2011 Feb 18;342:d1143. doi: 10.1136/bmj.d1143. No abstract available.
Glucagon-like peptide-1 analogues for type 2 diabetes.
Wilding JP, Hardy K.
BMJ. 2011 Feb 16;342:d410. doi: 10.1136/bmj.d410. No abstract available.
Type 1 diabetes in children.
Ali K, Harnden A, Edge JA.
BMJ. 2011 Feb 16;342:d294. doi: 10.1136/bmj.d294. No abstract available.
Peer support for patients with type 2 diabetes: cluster randomised controlled trial.
Smith SM, Paul G, Kelly A, Whitford DL, O'Shea E, O'Dowd T.
BMJ. 2011 Feb 15;342:d715. doi: 10.1136/bmj.d715.
Unanswered questions over NHS health checks.
Khunti K, Walker N, Sattar N, Davies M.
BMJ. 2010 Jan 26;342:c6312. doi: 10.1136/bmj.c6312. No abstract available.
Atypical diabetic retinopathy.
Ong HS, Moosavi AH, Althauser SR.
BMJ. 2011 Mar 9;342:d678. doi: 10.1136/bmj.d678. No abstract available.
Inpatient management of diabetic foot problems: summary of NICE guidance.
Tan T, Shaw EJ, Siddiqui F, Kandaswamy P, Barry PW, Baker M; Guideline Development Group.
BMJ. 2011 Mar 23;342:d1280. doi: 10.1136/bmj.d1280. No abstract available.
Weight loss and hyponatraemia.
Othonos N, Sulaiman R, D'Costa D, Gama R.
BMJ. 2011 Mar 2;342:d405. doi: 10.1136/bmj.d405. No abstract available.
The challenge of managing coexistent type 2 diabetes and obesity.
Bailey CJ.
BMJ. 2011 Apr 13;342:d1996. doi: 10.1136/bmj.d1996. Review. No abstract available.
Closed loop control for type 1 diabetes.
Kovatchev B.
BMJ. 2011 Apr 13;342:d1911. doi: 10.1136/bmj.d1911. No abstract available.
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.
Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML.
BMJ. 2011 Apr 13;342:d1855. doi: 10.1136/bmj.d1855.
Glucagon-like peptide-1 drugs. Are GLP-1 analogues affordable?
Macaulay D.
BMJ. 2011 Mar 8;342:d1482. doi: 10.1136/bmj.d1482. No abstract available.
Glucagon-like peptide-1 drugs. Use of GLP-1 analogues needs great caution.
Yudkin JS, Lehman R, Krumholz HM.
BMJ. 2011 Mar 8;342:d1478. doi: 10.1136/bmj.d1478. No abstract available.
Hypoglycaemia unawareness.
Cove DH.
BMJ. 2011 Mar 8;342:d1474. doi: 10.1136/bmj.d1474. No abstract available.
Hypoglycaemia. Avoid 50% dextrose.
Evans ML.
BMJ. 2011 Mar 8;342:d1470. doi: 10.1136/bmj.d1470. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on